8.2 billion USD Chinese conglomerate plans investments into US healthcare ventures

China based conglomerate AUX Group has announced plans to seek health services investments in the US and Britain, according to recent reports. The company has 8.2 billion USD in total assets and was named among China’s top 500 enterprises. The announcement comes after AUX Group’s planned 2.7 billion AUD investment into Healthscope, the second-largest operator…

Chinese investor makes multi-million dollar bid for French pharma company

Chinese investors specializing in healthcare are increasingly expanding into the European market with a series of high-profile, strategic investments. This is part of a trend of heightened healthcare deal activity from Chinese investors. Last year, companies based in China announced acquisitions in the medical industry worth 30.4 billion USD – representing twice the investment level…

Middle Eastern healthcare investors turn to the US for stable returns

Investors based in the Middle East and regional healthcare companies having been actively seeking acquisitions and investment opportunities in the US. Overseas investments provide Middle Eastern individuals and institutions with a way to diversify their portfolios, rather than overexposing their operations to a single market, as noted recently in Forbes. According to Dhiraj Joshi, a…

Chinese company acquires UK healthcare venture for 1.1 billion USD

In May 2016, Chinese investment group Creat Group agreed to acquire UK-based Bio Products Laboratory for 820 million GBP (1.1 billion USD). Headquartered in Hertfordshire, Bio Products Laboratory is a plasma biotherapeutics company that provides therapeutics for conditions related to bleeding disorders, immune deficiencies and critical care. Creat will invest an additional 100 million GBP…